Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
ENCODE Turns Human Genome From Sequence to Machine
This is Part 1 of a two-part story. See also Part 2.

19 September 2012. When the first human genome sequence was finished in 2003, it quickly became clear that its seemingly unending stream of letters was not enough to understand what makes people tick. All the moving parts that bring the DNA code to life needed to be understood as well. To address this, researchers launched the Encyclopedia Of DNA Elements (ENCODE) in 2003. More than 440 scientists collaborated to identify functional parts of the genome—those regions that regulate how, when, and where different genes are turned on or off. This month, the consortium released its latest data in a fusillade of papers, including six in the September 6 Nature. Together, the scientists found that about 80 percent of the genome, much of which was previously considered “junk” DNA, has at least one biochemical function in some cells. Though the scientists have not yet examined every human cell type, this latest effort widens their window into the intricacies of the genetic code. The data could help researchers understand how genetic variants found outside of genes can alter risk for disease, including neurodegenerative disorders such as Alzheimer’s (see Part 2). "This short-circuits a lot of work that you'd have to do to figure out signals from a genetic study," said Gerard Schellenberg, University of Pennsylvania School of Medicine, Pennsylvania.

ENCODE is funded by the National Human Genome Research Institute (NHGRI). Its public consortium of scientists, who hail from more than 30 institutions around the world, has so far examined 147 cell types in about 1,640 separate datasets to identify functional elements in human DNA. A Nature special feature helps navigate the findings, allowing users to search by topic thread or by individual paper. In more than 30 published papers, scientists map the genome by regions of transcription, transcription factor binding, histone modification, and methylation. A five-minute Nature YouTube video explains the rationale behind ENCODE.

"At the start of this project, most people thought that if genes make up 2 percent of the genome, maybe another 3 or 4 percent made up the instruction that controls them," said John Stamatoyannopoulos, University of Washington School of Medicine, Seattle, an ENCODE project leader. "It has been surprising just how much of the genome actually is involved."

One interesting map for those studying Alzheimer's disease and other neurodegenerative disorders pinpoints the genome's regulatory sites. These are the enhancers, promoters, insulators, and silencers (see Thurman et al., 2012). It turns out that almost 2.9 million regulatory regions populate the genome, 10 times more than expected at ENCODE's outset. Only 200,000 are active in any given cell at one time.

The researchers discovered the regulatory elements by identifying DNA sequences that had unwound from their histone spools in preparation to affect transcription elsewhere in the genome. By determining which stretches of DNA were active at the same time as certain promoters, researchers matched 20 percent of regulatory elements to specific genes that were regulated by them. Interestingly, non-coding single-nucleotide polymorphisms that turn up in genomewide association studies (GWAS) are often found in these very regions (see Part 2 of this series). In the Alzheimer’s field, researchers have associated non-coding polymorphisms with disease, but are struggling to interpret how they might alter risk (see ARF related news story).

"Understanding the genome sequence got us a long way in being able to do genetic studies of disease, but having this map of genome function is important for understanding the actual biology that leads to disease," said Stamatoyannopoulos.

Mapping regulatory elements will also allow researchers to find potentially important genomic regions for disease treatment, including for Alzheimer's disease (AD), said Schellenberg, who noted, for example, that tinkering with the regulation of β-secretase (BACE1)—one of the enzymes that produces Aβ—is one possible way to treat AD. "You can go into ENCODE and at least begin to see the potential regulatory units and networks to target," he said.

Companion papers offer more insight about control of gene transcription. For instance, researchers led by Job Dekker and Amartya Sanyal, both of the University of Massachusetts Medical School in Worcester, have begun to map long-range interactions between enhancers and gene promoters that are quite distant from each other in the genome but may come into contact when DNA is folded and coiled around histones (see Sanyal et al., 2012). They have mapped but 1 percent of the genome, but in doing so they found, among other things, that both enhancers and promoters can interact with multiple long-range partners.

In another study, scientists including Mark Gerstein of Yale University, New Haven, Connecticut, and Michael Snyder of Stanford University, California, have worked out how and where different combinations of 119 transcription factors bind to DNA to regulate gene activity (see Gerstein et al., 2012). Hundreds of other transcription factors remain to be analyzed; even so, this is one step toward understanding how networks of these regulatory proteins function and contribute to human disease, wrote the authors.

One shortcoming of ENCODE is that it did not sample brain tissue, Schellenberg noted. "There are many different kinds of cell types in the brain, many different kinds of neurons, and each probably has its own gene regulatory network." Stamatoyannopoulos said that researchers hope to look at more cell types associated with human disease, such as the brain, in the future.

ENCODE researchers still have a long road ahead before they reach a thorough understanding of how the genome behaves at different stages of development, in different tissues, and within individual cells of a heterogeneous tissue. Phase 3 of the project is dedicated to filling in these blanks. However, firsthand observation may not be necessary or even possible for every conceivable situation, wrote Eran Segal in an accompanying News and Views article. He suggested that when scientists learn enough about the genome, they may be able to predict how it will behave in different circumstances. "We must work towards deriving quantitative models that integrate the relevant protein, RNA, and chromatin components; describe how these components interact with each other; how they bind the genome; and how these binding events regulate transcription," he said. "If successful, such models will be able to predict the genome’s function at times and in settings that have not been directly measured."—Gwyneth Dickey Zakaib.

This is Part 1 of a two-part story. See also Part 2.

References:
ENCODE Project Consortium, Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012 Sep 6;489(7414):57-74. Abstract

Ecker JR, Bickmore WA, Barroso I, Pritchard JK, Gilad Y, Segal E. Genomics: ENCODE explained. Nature. 2012 Sep 6;489(7414):52-5. Abstract

Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, Garg K, John S, Sandstrom R, Bates D, Boatman L, Canfield TK, Diegel M, Dunn D, Ebersol AK, Frum T, Giste E, Johnson AK, Johnson EM, Kutyavin T, Lajoie B, Lee BK, Lee K, London D, Lotakis D, Neph S, Neri F, Nguyen ED, Qu H, Reynolds AP, Roach V, Safi A, Sanchez ME, Sanyal A, Shafer A, Simon JM, Song L, Vong S, Weaver M, Yan Y, Zhang Z, Zhang Z, Lenhard B, Tewari M, Dorschner MO, Hansen RS, Navas PA, Stamatoyannopoulos G, Iyer VR, Lieb JD, Sunyaev SR, Akey JM, Sabo PJ, Kaul R, Furey TS, Dekker J, Crawford GE, Stamatoyannopoulos JA. The accessible chromatin landscape of the human genome. Nature. 2012 Sep 6;489(7414):75-82. Abstract

Sanyal A, Lajoie BR, Jain G, Dekker J. The long-range interaction landscape of gene promoters. Nature. 2012 Sep 6;489(7414):109-13. Abstract

Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R, Min R, Alves P, Abyzov A, Addleman N, Bhardwaj N, Boyle AP, Cayting P, Charos A, Chen DZ, Cheng Y, Clarke D, Eastman C, Euskirchen G, Frietze S, Fu Y, Gertz J, Grubert F, Harmanci A, Jain P, Kasowski M, Lacroute P, Leng J, Lian J, Monahan H, O'Geen H, Ouyang Z, Partridge EC, Patacsil D, Pauli F, Raha D, Ramirez L, Reddy TE, Reed B, Shi M, Slifer T, Wang J, Wu L, Yang X, Yip KY, Zilberman-Schapira G, Batzoglou S, Sidow A, Farnham PJ, Myers RM, Weissman SM, Snyder M. Architecture of the human regulatory network derived from ENCODE data. Nature. 2012 Sep 6;489(7414):91-100. Abstract

 
Comments on News and Primary Papers
  Comment by:  P. Hemachandra Reddy
Submitted 20 September 2012  |  Permalink Posted 21 September 2012
  I recommend the Primary Papers
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad